Programme

(Preliminary)

Wednesday June 11th - Presymposium

08:30 - 09:45	Registration for presymposium and entire congress
09:45 - 10:00	Welcome
10:00 - 11:00	Norway 1. Amyloidosis in a nephrological perspective \| Dr. Tale Wien, Bærum 2. Who is the patient with amyloidosis? Characteristics and epidemiology \| Dr. Hilde Vasstrand, Bærum 3. AA-amyloidosis in peaople who inject drugs \| Dr. Helga Gudmundsdottir, Oslo
11:00 - 11:10	Break
11:10 - 12:10	Denmark CVD in CKD *Epidemiology of cardiovascular disease in CKD* \| Ellen Linnea Freese Ballegaard, Copenhagen University Hospital *CKD and cardiac arrythmias* \| Jesper Mosgaard Rantanen, University of Aalborg *Atherosclerotic renovascular disease* \| Mark Reinhard, University of Aarhus
12:10 - 12:20	Break
12:20 - 13:20	Sweden Different aspects on contributing mechanisms in ANCA-associated vasculitis *Genetics in ANCA-associated vasculitis* \| Johanna Dahlqvist, Uppsala University Hospital *Complement and complement inhibition at different levels in ANCA-associated vasculitis* \| Sophie Ohlsson, Lund University Neutrophils in ANCA-associated vasculitis \| Sandra Liljebladh, Lund University
13:20 - 14:50	Lunch break
13:45 - 14:45	Lunch symposium - sponsored by Novo Nordisk (Gold sponsor) Metabolic and Renal Interplay: Exploring Obesity, Diabetes, and Chronic Kidney Disease - Welcome and introduction \| Professor Trond Geir Jenssen - The interconnection between obesity, diabetes and chronic kidney disease \| Nephrologist Espen Nordheim - *GLP-1 Receptor Agonists in management of Chronic Kidney Disease* \| Professor Bård Waldum-Grevbo - *Closing* \| Professor Trond Geir Jenssen
14:50 - 15:50	Iceland 1. Incidence and outcome of community acquired acute kidney injury \| Telma H Ragnarsdóttir 2. Why do Icelandic dialysis patients have worse survival than other European dialysis patients \| Haraldur O Arnarsson 3. Can you prevent progression of chronic kidney disease in patients using lithium by stopping lithium treatment? \|Gísli .......Gíslason
15:50 - 16:00	Break
16:00 - 17:00	Finland *Update on primary aldosteronism* \| Pasi Nevalainen, Tampere University Hospital *CKD and frailty* \| Tapio Hellman, Turku University Hospital *Home dialysis and patient outcomes* \| Wisam Bitar, Helsinki University Hospital
17:00 - 17:15	Break
17:15 - 17:25	NSN Congress Opening
17:25 - 17:30	Break
17:30 - 18:30	Best abstract 1

Thursday June 12th - Congress

08:30 - 09:30	Expert panel discussion: Early CKD detection, prevention and referral \| Prof. Bård Waldum-Grevbo, Oslo, Prof. Maria Eriksson Svensson, Uppsala and Prof. Peter Rossing, Copenhagen
09:30 - 09:45	Break
09:45 - 10:45	Chairs: Dr. Marit Dahl Solbu, Tromsø and Dr. Lene V. Halvorsen, Oslo *Antihypertensive treatment in CKD* \| Docent Daniel Gordin, Helsinki Hypertension in Pregnancy \| Prof. Jana Brguljan Hitij, Ljubljana
10:45 - 11:00	Break
11:00 - 12:05	Chairs: Dr. Helga Gudmundsdottir, Oslo State of the art 1 Quality of life for elderly on dialysis therapy \| Prof. Edwina Brown, London
12:05 - 12:30	Break
12:30 - 13:30	Lunch symposium - sponsored by Vantive (Platinum sponsor) Extending Lives Expanding Possibilities PD cases: You decide - Experts guide. Chairman: Helga Gudmundsdottir, Nephrologist at OUS, Ullevål. Norway Treating patients with PD allows for increased freedom for life compared to HD. Modern PD is beneficial for patient outcomes and healthcare costs, while introduction of remote patient management systems has enabled safer treatment in patients’ homes. Join our session to hear how leading Nordic nephrologists in PD care see the challenges, and how they would overcome them with evidence based solutions.
13:30 - 13:40	Break
13:40 - 14:40	Chairs: Dr. Lene Heramb, Trondheim and Ulrika Hahn Lundström, Stockholm *Debunking the myths of PD* \| Dr. Stig Arne Kjellevold, Tønsberg *Maintaining a high prevalence of patients in PD* \| Dr. Helga Gudmundsdottir, Oslo TBD \| TBD
14:40 - 14:50	Break
14:50 - 16:05	Poster Session
16:05 - 16:30	Break
16:30 - 17:30	Industry symposium sponsored by Astra Zeneca (Platinum Sponsor) Transforming Care Together: A Multidisciplinary Approach to the CardioRenal-metabolic syndrome. Welcome and Introduction \| Ivar Anders Eide • Overview of GDMT (Guideline-Directed Medical Therapy) • Current Implementation Status in the Nordic Countries *The CVRM Triangle: Focus on the CKM Syndrome* \| Muthiah Vaduganathan, cardiologist at Brigham and Women’s Hospital and faculty at Harvard Medical School • SGLT2 Inhibitors and Renal Mechanisms • Hypertension as a Central Risk Factor *Addressing Barriers to GDMT in CKD* \| Bård Endre Waldum-Grevbo • RAAS blockade and the role of potassium binders
17:30 - 17:40	Break
17:40 - 18:00	Best abstract 2
19:00 - 21:00	Get Together Oslo City Hall (Rådhuset)

Friday June 13th - Congress

08:30 - 09:15	Chairs: Prof. Ilkka Helanterä and Prof. Kristian Heldal Pro’s and Con’s of Cardiovascular Screening before Kidney Transplantation \| Assoc. Prof. Simon Winther, Aarhus Cardiorenal Prophylaxis After Kidney Transplantation \| Prof. Trond Jenssen, Oslo
09:15 - 09:30	Break
09:30 - 10:45	Chairs: Prof. Susanne Dam Poulsen and Dr. Karsten Midtvedt *Vaccination of Solid Organ Transplant Candidates and Recipients – Experiences from a Structured Vaccination Clinic* \| Prof. Susanne Dam Poulsen, Copenhagen New Guidelines and New Treatments – Update on CMV and BKV after Kidney Transplantation \| Prof. Ilkka Helanterä, Helsinki Coping with EBV and Risk of PTLD - Recent Insights \| Dr. Lene Ugilt Pagter Ludvigsen, Aarhus
10:45 - 11:10	Break
11:10 - 12:00	Chairs Prof. Trond Jenssen and Prof. Kåre Birkeland State of the art 3 and plenary discussion *State-of-the-Art for Beta-Cell Replacement in Type 1 Diabetes: Stem Cell-Derived Islets and/or Gene-Modified Islet Cells Without the Need for Immunosuppression* \| Prof. Per Ola Carlsson, Uppsala
12:00 - 12:30	Break
12:30 - 13:30	Lunch symposium - sponsored by CSL Vifor (Platinum sponsor) What is the role of the complement system in ANCA-associated vasculitis? \| Associate professor Sophie Ohlsson, Lund University New therapeutic options in IgAN – a clinical perspective \| Professor Adrian Schreiber, Charité, University Hospital Berlin
13:30 - 13:40	Break
13:40 - 14:40	Chairs: Dr. Inga Strand Thorsen, Stavanger and Dr. Ruth Strømmen, Oslo *CKD MBD: The spectrum of bone diseases in chronic kidney disease* \| Assoc. Prof. Hanne Mari Skov Jørgensen, Aarhus CKD MBD: Preventing fractures in patients with CKD \| Prof. Syazrah Salam, Sheffield
14:40 - 14:50	Break
14:50 - 16:05	Poster Session
16:05 - 16:30	Break
16:30 - 17:30	Industry symposium - sponsored by Boehringer Ingelheim (Gold Sponsor) Title TBD
17:30 - 17:40	Break
17:40 - 18:00	Best abstract 3
19:00 -	Congress dinner

Saturday June 14th - Congress

09:00 - 10:30	Chairs: Dr. Thomas Knoop, Bergen and Prof. Øystein Eikrem, Bergen State of the art 3 and plenary discussion *Immunosuppressive therapy in IgA nephritis* \| Prof. Jonathan Barratt, Leicester and Dr.Yngvar Haaskjold, Trondheim *Setting the Scene and Current Goals in IgA Nephropathy* \| Prof. Jonathan Barratt, Leicester *Prognostic Models in IgA Nephropathy* \| Dr.Yngvar Haaskjold, Trondheim *Immunosuppressive Treatments in IgA Nephropathy: When, Which, and Duration?* \| Prof. Jonathan Barratt, Leicester *IgA Vasculitis: Similarities and Contrasts with IgA Nephropathy* \| Prof. Jonathan Barratt, Leicester Discussion \| Prof. Jonathan Barratt, Leicester
10:30 - 10:40	Break
10:40 - 11:50	Chairs: Dr Thomas Knoop, Bergen and Dr. Guri Stokke, Bodø *Advanced molecular profiling of FFPE kidney tissues* \| Prof. Øystein Eikrem, Bergen *MPGN and C3* \| Dr. Kati Kaartinen, Helsinki CAR-T cell theraphy in immune-mediated kidney diseases: future prospects an safety \| Dr. Yngvar Haaskjold, Trondheim
11:50- 12:05	Break
12:05 - 13:05	Lunch symposium - sponsored by Medice Nordic (Gold sponsor) Vadadustat INNO2VATIVE anaemia management for dialysis patients
13:05 - 13:15	Congress conclusion